Prognostic significance of overexpression of Traf2- and Nck- interacting kinase (TNIK) in colorectal cancer

NIAID Data Ecosystem2026-03-12 收录

结直肠癌预后

肿瘤生物标志物

数据链接：

https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE64258 数据链接链接失效反馈

官方服务：

资源简介：

This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

创建时间：

2021-01-07

Postoperative Serum Levels of sCD26 for Surveillance in Colorectal Cancer Patients

结直肠癌复发

肿瘤生物标志物

One of the main aims of the follow-up after curative resection of colorectal cancer is the early detection and treatment of tumor recurrence. We previously demonstrated decreased preoperative soluble

Figshare2016-01-15 更新50

Paleturquoise module genes.

泛基因组分析

肿瘤生物标志物

Next-generation sequencing technology enables uniform and impartial assessment of cancer diagnoses and prognosis. However, such studies are mostly type-specific, and capturing shared genomic abnormali

Figshare2025-05-30 更新40

BRCAness, SLFN11 and RB1 loss predict response to topoisomerase I inhibitors in triple negative breast cancers. BRCAness, SLFN11 and RB1 loss predict response to topoisomerase I inhibitors in triple negative breast cancers

乳腺癌药物反应

肿瘤生物标志物

Expression data from patient-derived xenografts of human triple-negative breast cancers Overall design: We used GeneChip Human 1.1 ST arrays to identify the genes differentially expressed in PDX with

NIAID Data Ecosystem20

Artificial neural network identified a 20-gene panel with promising value in predicting immunotherapy response and survival benefits after anti-PD1/PD-L1 treatment in GBM patients

GBM胶质母细胞瘤

肿瘤生物标志物

Question: Which biomarker can effectively predict the immunotherapy response and prognostic benefits of GBM patients, and how can potential responders to immune checkpoint inhibitors (ICIs) be disc

Figshare2021-02-25 更新40

Associations between HLA-G 3’UTR haplotypes with disease free survival and overall survival in 253 stage II-III CRC patients (N = 506).

结直肠癌预后

HLA-G单倍型分析

Associations between HLA-G 3’UTR haplotypes with disease free survival and overall survival in 253 stage II-III CRC patients (N = 506).

Figshare2016-02-23 更新20